Investigating how racial and social factors affect bladder cancer outcomes.

Racial and social contextual factors in relation to epigenome and bladder cancer outcome.

NIH-funded research Baylor College of Medicine · NIH-10932938

This study is looking at how race and social factors affect bladder cancer and aims to improve treatment and support for underserved communities, especially for minority patients, by bringing together experts from Baylor College of Medicine and Texas Southern University.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10932938 on NIH RePORTER

What this research studies

This research focuses on understanding the impact of racial and social contextual factors on the epigenome and outcomes for patients with bladder cancer. It aims to strengthen collaboration between Baylor College of Medicine and Texas Southern University to address cancer health disparities, particularly in underserved populations. The project will develop a cancer research program that emphasizes community engagement and education, targeting predominantly minority populations to improve access to treatment and outcomes. By leveraging the expertise of both institutions, the research seeks to create a robust infrastructure for addressing these disparities.

Who could benefit from this research

Good fit: Ideal candidates for this research include African American individuals diagnosed with bladder cancer or those at risk due to social and racial factors.

Not a fit: Patients who do not identify as part of the targeted underserved populations or those with other types of cancer may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment outcomes and access to care for bladder cancer patients from underserved communities.

How similar studies have performed: Other research has shown success in addressing cancer health disparities through community engagement and targeted interventions, indicating that this approach has potential for meaningful impact.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.